PUM2_HUMAN - dbPTM
PUM2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PUM2_HUMAN
UniProt AC Q8TB72
Protein Name Pumilio homolog 2
Gene Name PUM2
Organism Homo sapiens (Human).
Sequence Length 1066
Subcellular Localization Cytoplasm . Cytoplasmic granule . Cytoplasm, perinuclear region . The cytoplasmic granules are stress granules which are a dense aggregation in the cytosol composed of proteins and RNAs that appear when the cell is under stress. Colocalizes with NANO
Protein Description Sequence-specific RNA-binding protein that acts as a post-transcriptional repressor by binding the 3'-UTR of mRNA targets. Binds to an RNA consensus sequence, the Pumilio Response Element (PRE), 5'-UGUANAUA-3', that is related to the Nanos Response Element (NRE) (, PubMed:21397187). Mediates post-transcriptional repression of transcripts via different mechanisms: acts via direct recruitment of the CCR4-POP2-NOT deadenylase leading to translational inhibition and mRNA degradation. [PubMed: 22955276 Also mediates deadenylation-independent repression by promoting accessibility of miRNAs]
Protein Sequence MNHDFQALALESRGMGELLPTKKFWEPDDSTKDGQKGIFLGDDEWRETAWGASHHSMSQPIMVQRRSGQGFHGNSEVNAILSPRSESGGLGVSMVEYVLSSSPADKLDSRFRKGNFGTRDAETDGPEKGDQKGKASPFEEDQNRDLKQGDDDDSKINGRGLPNGMDADCKDFNRTPGSRQASPTEVVERLGPNTNPSEGLGPLPNPTANKPLVEEFSNPETQNLDAMEQVGLESLQFDYPGNQVPMDSSGATVGLFDYNSQQQLFQRTNALTVQQLTAAQQQQYALAAAQQPHIAGVFSAGLAPAAFVPNPYIISAAPPGTDPYTAAGLAAAATLAGPAVVPPQYYGVPWGVYPANLFQQQAAAAANNTASQQAASQAQPGQQQVLRAGAGQRPLTPNQGQQGQQAESLAAAAAANPTLAFGQGLATGMPGYQVLAPTAYYDQTGALVVGPGARTGLGAPVRLMAPTPVLISSAAAQAAAAAAAGGTASSLTGSTNGLFRPIGTQPPQQQQQQPSTNLQSNSFYGSSSLTNSSQSSSLFSHGPGQPGSTSLGFGSGNSLGAAIGSALSGFGSSVGSSASSSATRRESLSTSSDLYKRSSSSLAPIGQPFYNSLGFSSSPSPIGMPLPSQTPGHSLTPPPSLSSHGSSSSLHLGGLTNGSGRYISAAPGAEAKYRSASSTSSLFSSSSQLFPPSRLRYNRSDIMPSGRSRLLEDFRNNRFPNLQLRDLIGHIVEFSQDQHGSRFIQQKLERATPAERQMVFNEILQAAYQLMTDVFGNYVIQKFFEFGSLDQKLALATRIRGHVLPLALQMYGCRVIQKALESISSDQQVISEMVKELDGHVLKCVKDQNGNHVVQKCIECVQPQSLQFIIDAFKGQVFVLSTHPYGCRVIQRILEHCTAEQTLPILEELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVSEIRGKVLALSQHKFASNVVEKCVTHASRAERALLIDEVCCQNDGPHSALYTMMKDQYANYVVQKMIDMAEPAQRKIIMHKIRPHITTLRKYTYGKHILAKLEKYYLKNSPDLGPIGGPPNGML
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
21PhosphorylationGMGELLPTKKFWEPD
CCCCCCCCCCCCCCC
47.0022964224
22AcetylationMGELLPTKKFWEPDD
CCCCCCCCCCCCCCC
43.9926051181
32UbiquitinationWEPDDSTKDGQKGIF
CCCCCCCCCCCCCEE
64.91-
53PhosphorylationRETAWGASHHSMSQP
HHHCCCCCCCCCCCC
20.1427080861
56PhosphorylationAWGASHHSMSQPIMV
CCCCCCCCCCCCEEE
18.0727080861
58PhosphorylationGASHHSMSQPIMVQR
CCCCCCCCCCEEEEE
35.5027732954
58 (in isoform 3)Phosphorylation-35.5024719451
67PhosphorylationPIMVQRRSGQGFHGN
CEEEEECCCCCCCCC
37.3430266825
67 (in isoform 3)Phosphorylation-37.3424719451
75PhosphorylationGQGFHGNSEVNAILS
CCCCCCCCCCCEEEC
47.7330266825
75 (in isoform 3)Phosphorylation-47.7327251275
82PhosphorylationSEVNAILSPRSESGG
CCCCEEECCCCCCCC
16.5022167270
82 (in isoform 3)Phosphorylation-16.5024719451
85O-linked_GlycosylationNAILSPRSESGGLGV
CEEECCCCCCCCCCH
39.2330059200
85PhosphorylationNAILSPRSESGGLGV
CEEECCCCCCCCCCH
39.2322167270
87PhosphorylationILSPRSESGGLGVSM
EECCCCCCCCCCHHH
39.1322167270
87 (in isoform 3)Phosphorylation-39.1327251275
93PhosphorylationESGGLGVSMVEYVLS
CCCCCCHHHEEHHHH
18.4722167270
97PhosphorylationLGVSMVEYVLSSSPA
CCHHHEEHHHHCCCH
8.6922167270
100PhosphorylationSMVEYVLSSSPADKL
HHEEHHHHCCCHHHH
20.8022167270
101PhosphorylationMVEYVLSSSPADKLD
HEEHHHHCCCHHHHH
35.8622167270
101 (in isoform 3)Phosphorylation-35.8624719451
102PhosphorylationVEYVLSSSPADKLDS
EEHHHHCCCHHHHHH
22.2622167270
102 (in isoform 3)Phosphorylation-22.2627251275
109PhosphorylationSPADKLDSRFRKGNF
CCHHHHHHHHCCCCC
43.7030278072
128AcetylationAETDGPEKGDQKGKA
CCCCCCCCCCCCCCC
71.5626051181
136PhosphorylationGDQKGKASPFEEDQN
CCCCCCCCCCCCHHC
33.3429255136
136 (in isoform 3)Phosphorylation-33.3424719451
175PhosphorylationDCKDFNRTPGSRQAS
CCCCCCCCCCCCCCC
32.8623401153
175 (in isoform 3)Phosphorylation-32.8624719451
178PhosphorylationDFNRTPGSRQASPTE
CCCCCCCCCCCCHHH
23.5625159151
178 (in isoform 3)Phosphorylation-23.5624719451
182PhosphorylationTPGSRQASPTEVVER
CCCCCCCCHHHHHHH
24.8219664994
182 (in isoform 3)Phosphorylation-24.8224719451
184PhosphorylationGSRQASPTEVVERLG
CCCCCCHHHHHHHHC
38.6322167270
184 (in isoform 3)Phosphorylation-38.63-
396PhosphorylationGAGQRPLTPNQGQQG
CCCCCCCCCCCCCHH
23.9127273156
408PhosphorylationQQGQQAESLAAAAAA
CHHHHHHHHHHHHHH
26.7326074081
432PhosphorylationLATGMPGYQVLAPTA
HHCCCCCCEEECCEE
6.9228464451
454MethylationLVVGPGARTGLGAPV
EEECCCCCCCCCCCC
34.9381452739
462MethylationTGLGAPVRLMAPTPV
CCCCCCCEEECCCCE
20.0726493963
540UbiquitinationSQSSSLFSHGPGQPG
CCCCCCCCCCCCCCC
32.59-
587PhosphorylationSSATRRESLSTSSDL
CHHHHHHHCCCCHHH
26.3029255136
587 (in isoform 3)Phosphorylation-26.3024719451
589PhosphorylationATRRESLSTSSDLYK
HHHHHHCCCCHHHHH
35.2129255136
590PhosphorylationTRRESLSTSSDLYKR
HHHHHCCCCHHHHHH
37.2329255136
591PhosphorylationRRESLSTSSDLYKRS
HHHHCCCCHHHHHHC
20.6223403867
592PhosphorylationRESLSTSSDLYKRSS
HHHCCCCHHHHHHCC
31.5523927012
593 (in isoform 2)Ubiquitination-54.5121890473
595PhosphorylationLSTSSDLYKRSSSSL
CCCCHHHHHHCCCCC
14.89-
596UbiquitinationSTSSDLYKRSSSSLA
CCCHHHHHHCCCCCC
53.7721906983
596 (in isoform 1)Ubiquitination-53.7721890473
596 (in isoform 3)Ubiquitination-53.7721890473
616AcetylationFYNSLGFSSSPSPIG
CHHCCCCCCCCCCCC
28.2719608861
616PhosphorylationFYNSLGFSSSPSPIG
CHHCCCCCCCCCCCC
28.2726074081
616UbiquitinationFYNSLGFSSSPSPIG
CHHCCCCCCCCCCCC
28.2719608861
617PhosphorylationYNSLGFSSSPSPIGM
HHCCCCCCCCCCCCC
43.9626074081
618PhosphorylationNSLGFSSSPSPIGMP
HCCCCCCCCCCCCCC
28.3526074081
620PhosphorylationLGFSSSPSPIGMPLP
CCCCCCCCCCCCCCC
30.9726074081
628PhosphorylationPIGMPLPSQTPGHSL
CCCCCCCCCCCCCCC
55.1326074081
630PhosphorylationGMPLPSQTPGHSLTP
CCCCCCCCCCCCCCC
35.2626074081
634PhosphorylationPSQTPGHSLTPPPSL
CCCCCCCCCCCCCCC
39.5926074081
636PhosphorylationQTPGHSLTPPPSLSS
CCCCCCCCCCCCCCC
36.4426074081
640PhosphorylationHSLTPPPSLSSHGSS
CCCCCCCCCCCCCCC
46.8126074081
642PhosphorylationLTPPPSLSSHGSSSS
CCCCCCCCCCCCCCC
25.3226074081
643PhosphorylationTPPPSLSSHGSSSSL
CCCCCCCCCCCCCCE
36.8426074081
646PhosphorylationPSLSSHGSSSSLHLG
CCCCCCCCCCCEECC
22.9426074081
647PhosphorylationSLSSHGSSSSLHLGG
CCCCCCCCCCEECCC
28.6526074081
648PhosphorylationLSSHGSSSSLHLGGL
CCCCCCCCCEECCCC
38.3226074081
649PhosphorylationSSHGSSSSLHLGGLT
CCCCCCCCEECCCCC
23.0426074081
662PhosphorylationLTNGSGRYISAAPGA
CCCCCCCEEECCCCC
11.6228152594
664PhosphorylationNGSGRYISAAPGAEA
CCCCCEEECCCCCCE
14.9428442448
672UbiquitinationAAPGAEAKYRSASST
CCCCCCEEECCCCCC
32.4721890473
672AcetylationAAPGAEAKYRSASST
CCCCCCEEECCCCCC
32.4719608861
672UbiquitinationAAPGAEAKYRSASST
CCCCCCEEECCCCCC
32.4719608861
672 (in isoform 1)Ubiquitination-32.4721890473
672 (in isoform 3)Acetylation-32.47-
672 (in isoform 3)Ubiquitination-32.4721890473
673PhosphorylationAPGAEAKYRSASSTS
CCCCCEEECCCCCCH
19.49-
674MethylationPGAEAKYRSASSTSS
CCCCEEECCCCCCHH
25.66-
675PhosphorylationGAEAKYRSASSTSSL
CCCEEECCCCCCHHH
29.4323186163
677PhosphorylationEAKYRSASSTSSLFS
CEEECCCCCCHHHCC
35.0823186163
678PhosphorylationAKYRSASSTSSLFSS
EEECCCCCCHHHCCC
31.8323186163
679PhosphorylationKYRSASSTSSLFSSS
EECCCCCCHHHCCCC
21.6023186163
680PhosphorylationYRSASSTSSLFSSSS
ECCCCCCHHHCCCCC
27.3023186163
681PhosphorylationRSASSTSSLFSSSSQ
CCCCCCHHHCCCCCC
33.2628555341
684PhosphorylationSSTSSLFSSSSQLFP
CCCHHHCCCCCCCCC
34.3023186163
685PhosphorylationSTSSLFSSSSQLFPP
CCHHHCCCCCCCCCH
27.0328985074
686PhosphorylationTSSLFSSSSQLFPPS
CHHHCCCCCCCCCHH
22.3923186163
687PhosphorylationSSLFSSSSQLFPPSR
HHHCCCCCCCCCHHH
32.6223917254
691UbiquitinationSSSSQLFPPSRLRYN
CCCCCCCCHHHHCCC
34.25-
693PhosphorylationSSQLFPPSRLRYNRS
CCCCCCHHHHCCCHH
44.1528985074
694MethylationSQLFPPSRLRYNRSD
CCCCCHHHHCCCHHH
29.0281452747
697PhosphorylationFPPSRLRYNRSDIMP
CCHHHHCCCHHHCCC
21.3728555341
700PhosphorylationSRLRYNRSDIMPSGR
HHHCCCHHHCCCCCH
28.0528348404
700 (in isoform 3)Phosphorylation-28.0524719451
705PhosphorylationNRSDIMPSGRSRLLE
CHHHCCCCCHHHHHH
29.4723186163
747UbiquitinationGSRFIQQKLERATPA
HHHHHHHHHHHCCHH
35.62-
762UbiquitinationERQMVFNEILQAAYQ
HHHHHHHHHHHHHHH
33.34-
768PhosphorylationNEILQAAYQLMTDVF
HHHHHHHHHHHHHHH
12.7524043423
772PhosphorylationQAAYQLMTDVFGNYV
HHHHHHHHHHHHHHH
37.2924043423
778PhosphorylationMTDVFGNYVIQKFFE
HHHHHHHHHHHHHHH
10.1824043423
792UbiquitinationEFGSLDQKLALATRI
HCCCHHHHHHHHHHH
35.08-
818 (in isoform 3)Ubiquitination-43.76-
843UbiquitinationELDGHVLKCVKDQNG
HHCCCEEEEEECCCC
35.57-
846UbiquitinationGHVLKCVKDQNGNHV
CCEEEEEECCCCCCH
64.17-
856UbiquitinationNGNHVVQKCIECVQP
CCCCHHHHHHHHHCC
26.10-
885 (in isoform 2)Ubiquitination-22.6621890473
906UbiquitinationAEQTLPILEELHQHT
HHHHHHHHHHHHHHH
3.85-
940AcetylationGRPEDKSKIVSEIRG
CCCCCHHHHHHHHHH
53.5225953088
956AcetylationVLALSQHKFASNVVE
HHHHHHHHHHHHHHH
34.6826051181
962 (in isoform 3)Ubiquitination-7.3321890473
964UbiquitinationFASNVVEKCVTHASR
HHHHHHHHHHHHHHH
23.542190698
964 (in isoform 1)Ubiquitination-23.5421890473
988UbiquitinationVCCQNDGPHSALYTM
HHCCCCCCCHHHHHH
22.56-
990PhosphorylationCQNDGPHSALYTMMK
CCCCCCCHHHHHHHH
24.0927732954
993PhosphorylationDGPHSALYTMMKDQY
CCCCHHHHHHHHHHH
7.7227732954
994PhosphorylationGPHSALYTMMKDQYA
CCCHHHHHHHHHHHH
16.1927732954
1000PhosphorylationYTMMKDQYANYVVQK
HHHHHHHHHHHHHHH
13.62-
1003PhosphorylationMKDQYANYVVQKMID
HHHHHHHHHHHHHHH
8.2028152594
1023AcetylationQRKIIMHKIRPHITT
HHHHHHHHHHCCHHH
24.0325953088
1029PhosphorylationHKIRPHITTLRKYTY
HHHHCCHHHCHHHCC
19.4223312004
1030PhosphorylationKIRPHITTLRKYTYG
HHHCCHHHCHHHCCH
24.7823312004
1034PhosphorylationHITTLRKYTYGKHIL
CHHHCHHHCCHHHHH
9.96-
1036PhosphorylationTTLRKYTYGKHILAK
HHCHHHCCHHHHHHH
22.53-
1046UbiquitinationHILAKLEKYYLKNSP
HHHHHHHHHHHHCCC
50.02-
1047PhosphorylationILAKLEKYYLKNSPD
HHHHHHHHHHHCCCC
12.4927690223
1048PhosphorylationLAKLEKYYLKNSPDL
HHHHHHHHHHCCCCC
23.4427690223
1050 (in isoform 3)Phosphorylation-38.9824719451
1052PhosphorylationEKYYLKNSPDLGPIG
HHHHHHCCCCCCCCC
20.4325159151

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of PUM2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PUM2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PUM2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PUM2_HUMANPUM2physical
12690449
NANO1_HUMANNANOS1physical
12690449
AURKA_HUMANAURKAphysical
21589936
DAZL_HUMANDAZLphysical
12511597
NANO3_HUMANNANOS3physical
18089289

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PUM2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-672, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82; SER-136; SER-182 ANDTHR-184, AND MASS SPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-136 AND SER-182, ANDMASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-182, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82; SER-136; SER-178;SER-182; THR-184 AND SER-587, AND MASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-136, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-182, AND MASSSPECTROMETRY.

TOP